Term Life Insurance for Weight Loss

GLP-1 medications like Wegovy, Ozempic, and Mounjaro are increasingly accepted by life insurance carriers. The rate impact depends primarily on your current BMI and overall health rather than the specific medication. If the medication has helped you achieve a healthy BMI and improved your metabolic markers, this can work in your favor during underwriting. Some carriers may still classify GLP-1 use under diabetic guidelines, so working with a licensed agent in our network who understands each carrier's approach is valuable. Actual premiums vary by carrier and individual underwriting.

This depends on your timeline and coverage needs. If you can wait 6-12 months for your weight loss to stabilize at a lower BMI, you may qualify for a better rate class. However, if you need coverage now, apply for coverage at your current health status and consider applying for a new policy later at a better rate class once your weight stabilizes. Never delay necessary coverage solely for rate optimization. A licensed agent in our network can help you plan the most strategic approach.

BMI is a significant factor in life insurance underwriting, with specific thresholds varying by carrier. Generally, BMI under 27 qualifies for Preferred rates, 27-30 for Standard Plus, 30-35 for Standard, and above 35 for Table ratings. These ranges vary by carrier and are considered alongside other health factors. Weight loss medication that helps you cross into a lower BMI category can meaningfully improve your rate class. These are illustrative ranges; actual premiums vary by carrier and individual underwriting.

Once your term life policy is issued and in force, your premiums remain level for the entire term period regardless of weight changes. The underwriting and rate determination are based on your health at the time of application. Weight regain after policy issuance does not increase your premiums or reduce your coverage during the term. This is one advantage of locking in rates while your health metrics are at their best.

Yes, some carriers underwrite GLP-1 medications differently depending on whether they are prescribed for obesity or Type 2 diabetes. When prescribed solely for weight management in a non-diabetic individual, some carriers are more favorable. When prescribed for diabetes management, the diabetic underwriting guidelines may apply. The distinction matters, so ensure your application accurately reflects the reason for your prescription. A licensed agent in our network can identify which carriers handle this distinction most favorably. All coverage is subject to underwriting approval by the issuing carrier.